Concentrix Narrows FY2026 Adj EPS Guidance from $10.83-$11.18 to $10.97-$11.09 vs $11.38 Est; Lowers FY2026 Sales Guidance from $9.925B-$10.025B to $9.827B-$9.877B vs $10.015B Est

Benzinga Newsdesk www.benzinga.com Negative 63.7%

Neg 63.7% Neu 0% Pos 0%

Concentrix (NASDAQ:CNXC) narrows FY2026 Adj EPS guidance from $10.83-$11.18 to $10.97-$11.09 vs $11.38 analyst estimate. Lowers FY2026 sales outlook from $9.925 billion-$10.025 billion to $9.827 billion-$9.877 billion vs $10.015 billion estimate.